Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +10
  • Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

    Not recruiting

    2 1 1
    Investigated drugs:
    Belgium France Germany The Netherlands
  • Study of Avelumab and Lenvatinib for Children with Central Nervous System Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Germany
  • Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Belgium Finland France Germany Hungary Italy +4
  • Study on Health, Activity, and Joint Outcomes in Patients Aged 13-69 with Severe or Moderate Hemophilia A Using Emicizumab

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Germany Hungary Italy Spain
  • Long-term Safety and Efficacy Study of Onasemnogene Abeparvovec in Patients with Spinal Muscular Atrophy

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France Italy
  • Study on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Lithuania The Netherlands Poland Portugal +3
  • Study Comparing Tacrolimus Levels in Children with Organ Transplants Switching from Prograf to Advagraf

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia
  • Study on Mepolizumab for Children and Teens with Hypereosinophilic Syndrome

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands Spain
  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Bulgaria Czechia Denmark France Germany Greece +5